MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis.
Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India.
Seroprevalence and significance of antibodies to hepatitis C virus in pediatric patients with malignant diseases.
Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases.
Antibodies to hepatitis C virus in patients with hepatocellular carcinoma.
Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population.
High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease.
Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma.
Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA.
High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan.
Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease.
Anti-GOR and hepatitis C virus in autoimmune liver diseases.
High incidence of hepatitis C virus antibodies in hemodialysis patients.
Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?
High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies.
To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease.
The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia.
Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them.
Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.
Hepatitis C virus antibodies in dialysis pediatric patients.
Hepatitis C virus RNA and hepatitis C virus antibody in the serum of patients with abnormal liver function.
High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma.
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.
Prevalence of antibodies to hepatitis C virus in patients with various types of liver diseases.
Hepatitis C virus (HCV) is known to be a major cause of non-A, non-B hepatitis (NANBH) and is thought to be an important causative agent of serious li...
292KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis.
Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India.
Seroprevalence and significance of antibodies to hepatitis C virus in pediatric patients with malignant diseases.
Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases.
Antibodies to hepatitis C virus in patients with hepatocellular carcinoma.
Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population.
High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease.
Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma.
Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA.
High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
